ZAG-101
Asset
Therapy preserving insulin-producing beta-cell function in autoimmune diabetes.
- Stage
- Phase 1
- Modality
- Other
- Target
- Inflammation
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Type 1 diabetes
Phase 1, businesswire.com, 5 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors3
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.